{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:33:11Z","timestamp":1792099991195,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"National Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["High level key disciplines of Medicine of National Administration of Traditional Chinese Medicine"],"award-info":[{"award-number":["High level key disciplines of Medicine of National Administration of Traditional Chinese Medicine"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157434","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:23:54Z","timestamp":1760999034000},"page":"157434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Huangjia Ruangan granules with entecavir for fibrosis regression in Chroinc Hepatitis B: A multicenter, randomized, double-blind, phase II trial"],"prefix":"10.1016","volume":"148","author":[{"given":"Xiaojun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-6369","authenticated-orcid":false,"given":"Jinghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Liangpunsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-143X","authenticated-orcid":false,"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phymed.2025.157434_bib0010","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global burden of disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMa Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157434_bib0001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.157434_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8105306","article-title":"Huangjia Ruangan granule inhibits inflammation in a rat model with liver fibrosis by regulating TNF\/MAPK and NF-\u03bab signaling pathways","volume":"2022","author":"Cai","year":"2022","journal-title":"Evid. Based Complem. Altern. Med."},{"key":"10.1016\/j.phymed.2025.157434_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.12688\/wellcomeopenres.17941.2","article-title":"Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?","volume":"7","author":"Campbell","year":"2023","journal-title":"Wellcome Open. Res."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/M16-2977","article-title":"CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration","volume":"167","author":"Cheng","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"Pt 1","key":"10.1016\/j.phymed.2025.157434_bib0005","article-title":"Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis","volume":"319","author":"Dan","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157434_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1749-8546-4-16","article-title":"Chinese medicines as a resource for liver fibrosis treatment","volume":"4","author":"Feng","year":"2009","journal-title":"Chin. Med."},{"key":"10.1016\/j.phymed.2025.157434_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103029","article-title":"Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis","volume":"69","author":"Fu","year":"2024","journal-title":"Redox. Biol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0011","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1142\/S0192415X22500197","article-title":"Notoginsenoside R1, an active compound from Panax notoginseng, inhibits hepatic stellate cell activation and liver fibrosis via MAPK signaling pathway","volume":"50","author":"Gong","year":"2022","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2025.157434_bib0012","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fct.2013.02.051","article-title":"Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-\u03b3 expression and inhibition of PI3K\/Akt pathway","volume":"56","author":"Guo","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.phymed.2025.157434_bib0013","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.phymed.2025.157434_bib0014","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","article-title":"A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis","volume":"72","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157434_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.phymed.2025.157434_bib0018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1473-3099(20)30692-7","article-title":"Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial","volume":"21","author":"Hsu","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.phymed.2025.157434_bib0017","first-page":"1012","article-title":"Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-\u03b21\/smads signaling pathway","volume":"10","author":"Hu","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.phymed.2025.157434_bib0016","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/molecules29010236","article-title":"Salvianolic acid B alleviates liver injury by regulating lactate-mediated histone lactylation in macrophages","volume":"29","author":"Hu","year":"2024","journal-title":"Molecules."},{"key":"10.1016\/j.phymed.2025.157434_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109098","article-title":"Gallic acid and ferulic acid protect the liver from thioacetamide-induced fibrosis in rats via differential expression of miR-21, miR-30 and miR-200 and impact on TGF-\u03b21\/Smad3 signaling","volume":"324","author":"Hussein","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.phymed.2025.157434_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.phymed.2025.157434_bib0022","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.14309\/ajg.0000000000001239","article-title":"Unreliable estimation of fibrosis regression during treatment by liver stiffness measurement in patients with chronic Hepatitis B","volume":"116","author":"Ji","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phymed.2025.157434_bib0021","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jhep.2022.07.018","article-title":"Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B","volume":"77","author":"Ji","year":"2022","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phymed.2025.157434_bib0023","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.phymed.2025.157434_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105728","article-title":"The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phymed.2025.157434_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/etm.2012.752","article-title":"Puerarin alleviates liver fibrosis via inhibition of the ERK1\/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats","volume":"18","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phymed.2025.157434_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.157434_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110550","article-title":"Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting pdgfr\u03b2","volume":"122","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.phymed.2025.157434_bib0028","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1142\/S0192415X2350057X","article-title":"Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the NF-kB\/HIF-1\u03b1 pathway in CCl4-induced liver fibrosis","volume":"51","author":"Liu","year":"2023","journal-title":"Am. J. Chin. Med."},{"issue":"9865","key":"10.1016\/j.phymed.2025.157434_bib0029","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phymed.2025.157434_bib0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2168.2002.02111.x","article-title":"Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours","volume":"89","author":"Ohlsson","year":"2002","journal-title":"Br. J. Surg."},{"issue":"3","key":"10.1016\/j.phymed.2025.157434_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/atm.2017.01.28","article-title":"Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection","volume":"5","author":"Parikh","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.phymed.2025.157434_bib0032","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1111\/j.1572-0241.2008.02086.x","article-title":"Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis","volume":"103","author":"Schiff","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phymed.2025.157434_bib0033","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.157434_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112689","article-title":"A network pharmacology approach to investigating the mechanism of tanshinone IIA for the treatment of liver fibrosis","volume":"253","author":"Shi","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.phymed.2025.157434_bib0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phymed.2025.157434_bib0036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of Hepatitis B Virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends. Microbiol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0037","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phymed.2025.157434_bib0038","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3350\/cmh.2014.20.3.228","article-title":"Prediction of fibrosis progression in chronic viral hepatitis","volume":"20","author":"Wong","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157434_bib0039","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.29523","article-title":"NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice","volume":"67","author":"Wree","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.157434_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106737","article-title":"Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis\/early cirrhosis in patients with chronic HBV infection: a multicenter, randomized clinical trial","volume":"190","author":"Xing","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phymed.2025.157434_bib0041","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3892\/etm.2022.11413","article-title":"Tanshinone IIA regulates the TGF-\u03b21\/smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis","volume":"24","author":"Xu","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.phymed.2025.157434_bib0042","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2025.157434_bib0043","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.fitote.2014.10.009","article-title":"Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1\u03b1 through mTOR-dependent pathway","volume":"99","author":"Zhao","year":"2014","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.phymed.2025.157434_bib0044","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1142\/S0192415X19500794","article-title":"Inhibitory effect of Corilagin on miR-21-regulated hepatic fibrosis signaling pathway","volume":"47","author":"Zhou","year":"2019","journal-title":"Am. J. Chin. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325010712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325010712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:26:38Z","timestamp":1769811998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325010712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0944711325010712"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157434","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huangjia Ruangan granules with entecavir for fibrosis regression in Chroinc Hepatitis B: A multicenter, randomized, double-blind, phase II trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157434"}}